Hereditary cancer screening: Case reports and review of literature on ten Ashkenazi Jewish founder mutations

Molecular Genetics & Genomic Medicine
Devin M CoxDebra L Collins

Abstract

Historically, three founder mutations in the BRCA1/2 (OMIM 113705; OMIM 600185) genes have been the focus of cancer risks within the Ashkenazi Jewish (AJ) population. However, there are several additional mutations associated with increased susceptibility to cancer in individuals of AJ ancestry. We report three patients who exemplify the need to keep these additional founder mutations in mind when pursuing hereditary cancer genetic testing of individuals in this population. All gene sequences in this paper were aligned to reference sequences based on human genome build GRCh37/UCSC hg19. review of the literature discusses that the combined risk is 12.36%-20.83% forhaving 1 of the 10 hereditary cancer AJ founder mutations in the BRCA1, BRCA2, CHEK2 (OMIM 604373), APC (OMIM 611731), MSH2 (OMIM 609309), MSH6 (OMIM 600678), and GREM1 (OMIM 603054) genes for individuals of AJ ancestry. We recommend testing for all 10 of these AJ founder cancer susceptibility mutations for individuals within this population as standard screening in order to ensure appropriate cancer risk management and cascade testing.

References

Sep 1, 1997·Nature Genetics·S J LakenB Vogelstein
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas S FrankGregory C Critchfield
Sep 27, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R FerlaA Russo
Aug 5, 2008·American Journal of Obstetrics and Gynecology·Ofer LavieGad Rennert
Apr 7, 2012·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Shiri Shkedi-RafidEphrat Levy-Lahad
Apr 12, 2013·American Journal of Epidemiology·Jing LiangYashuang Zhao
Jul 31, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ben BoursiSarah Kraus
Dec 6, 2014·Breast Cancer Research and Treatment·Eric RosenthalRichard J Wenstrup
Oct 19, 2016·Cancer Genetics·Tracey P LeedomElizabeth C Chao

❮ Previous
Next ❯

Citations

Jun 13, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·A N BuiV E Nambudiri
Jul 18, 2020·Cancer Research·Jacquelyn PowersKara N Maxwell
Jul 3, 2021·The Urologic Clinics of North America·Tala BerroSaud H AlDubayan
Oct 24, 2021·Genes, Chromosomes & Cancer·Dianne E SylvesterJennifer A Byrne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.